PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. The company is headquartered in Lyon, France. Show more

60 AVENUE ROCKEFELLER, LYON, FRANCE, 69008, USA

https://www.phaxiam.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

28.9M

52 Wk Range

$0.00 - $0.00

Previous Close

$3.10

Open

$3.10

Volume

N/A

Day Range

$3.10 - $3.10

Enterprise Value

0.00

Cash

10.47M

Avg Qtr Burn

-12.55M

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

12/31/22

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PHAXIAM phages Details Staph aureus , Prosthetic joint infection	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PHAXIAM phages Details Endocarditis infections, Staph aureus	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Eryaspase (GRASPA) (asparaginase) Details Pancreatic cancer, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Eryaspase (GRASPA) (asparaginase) Details Breast cancer, Triple-negative breast cancer , Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Eryaspase (GRASPA) (asparaginase) Details Leukemia, Acute lymphoblastic leukemia, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Eryaspase (GRASPA) (asparaginase) Details Pancreatic cancer, Solid tumor/s, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.